You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Human growth hormone and glutamine for patients with short bowel syndrome
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2010
|
| DOI | 10.1002/14651858.cd006321.pub2 |
| Pubmed ID | |
| Authors |
Paul W Wales, Ahmed Nasr, Nicole de Silva, Janet Yamada |
| Abstract |
There has been clinical enthusiasm for treating short bowel patients with human recombinant growth hormone and/or glutamine in hopes of reducing parenteral nutrition dependency. It has been more than a decade since Byrne and colleagues reported enhanced absorption of nutrients, improved weight gain, and reduction in parenteral nutrition requirements with the administration of a combination of human growth hormone (HGH) and glutamine in patients with short bowel syndrome. Other studies have reported inconsistent results. |
Mendeley readers
The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ireland | 1 | <1% |
| Unknown | 137 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 27 | 20% |
| Student > Bachelor | 17 | 12% |
| Researcher | 14 | 10% |
| Student > Ph. D. Student | 10 | 7% |
| Other | 7 | 5% |
| Other | 23 | 17% |
| Unknown | 40 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 35% |
| Nursing and Health Professions | 16 | 12% |
| Social Sciences | 5 | 4% |
| Agricultural and Biological Sciences | 5 | 4% |
| Psychology | 3 | 2% |
| Other | 9 | 7% |
| Unknown | 52 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2014.
All research outputs
#22,830,803
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#11,281
of 11,499 outputs
Outputs of similar age
#92,299
of 96,735 outputs
Outputs of similar age from Cochrane database of systematic reviews
#71
of 75 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,735 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.